ofloxacin and Infections, Helicobacter

ofloxacin has been researched along with Infections, Helicobacter in 149 studies

Research

Studies (149)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.67)	18.2507
2000's	73 (48.99)	29.6817
2010's	73 (48.99)	24.3611
2020's	2 (1.34)	2.80

Authors

Authors	Studies
He, XJ; Jiang, CS; Li, DZ; Liu, G; Wang, W; Zeng, XP	2
Imai, Y; Inokuma, T; Matsumoto, T	1
Gisbert, JP; Marin, AC; McNicholl, AG	1
Graham, DY; Liang, X; Liao, J; Liu, W; Lu, H; Sun, Q; Xiao, S; Zhang, W; Zheng, Q	1
Calhan, T; Doganay, HL; Kahraman, R; Kanat, E; Ozdil, K; Sahin, A; Senates, E; Sokmen, HM	1
Ahmadiyan, N; Mohammadzadeh, R	1
Ang, TL; Song, M	1
Shokri-Shirvani, J; Zamani, M; Zamani, V	1
Baik, SJ; Ha, CY; Jung, HS; Jung, JM; Jung, SA; Kang, MJ; Na, YJ; Shim, KN; Yoo, K	1
Cozzolino, D; Iovene, MR; Nardone, G; Pilloni, AP; Rocco, A; Romano, M; Russo, MI; Salerno, R; Tufano, MA; Vaira, D	1
Hagymási, K; Tulassay, Z	1
Di Caro, S; Franceschi, F; Gasbarrini, A; La Rocca, E; Mariani, A; Masci, E; Raimondo, D; Testoni, A; Thompson, F	1
Liu, LN; Zhang, ZF; Zhao, G	1
Coelho, L; Moretzsohn, L; Sanches, B; Vieira, G	1
Chang, LL; Chen, A; Hsu, PI; Hu, HM; Jan, CM; Kuo, CH; Kuo, FC; Li, CJ; Tsai, PY; Wang, SW; Wang, WM; Weng, BC; Wu, DC; Wu, IC; Yu, FJ	1
de Boer, WA; Janssen, MJ; Schrauwen, RW	1
Barbuti, RC; Eisig, JN; Malfertheiner, P; Moraes Filho, JP; Rodriguez, TN; Silva, FM; Zaterka, S	1
Chang, WL; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB; Yang, YJ	1
Barrio, J; Castro-Fernández, M; Cosme, A; Gisbert, JL; Gisbert, JP; Marcos, S; Moreno-Otero, R; Pérez-Aisa, A; Rodrigo, L	1
Katelaris, PH	1
Kandulski, A; Malfertheiner, P; Selgrad, M	1
But, D; Chan, CK; Chan, FS; Chan, P; Cheung, TK; Chu, KM; Gu, Q; Hsu, A; Hung, IF; Leung, S; Seto, WK; Tong, TS; Wong, BC; Wong, SY	1
Aydin, A; Musoglu, A; Oruc, N; Ozutemiz, O; Tuncyurek, M; Turan, I	1
Angelini, R; Pontone, P; Pontone, S; Standoli, M	1
Cristofari, F; De Francesco, V; Hassan, C; Iegri, C; Zullo, A	1
Abadia, EG; Dueñas, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Perez-Gallardo, B; Vinagre, G	1
Levy, I; Samra, Z; Shmuely, H; Yahav, J; Zevit, N	1
Hibi, T; Nishizawa, T; Suzuki, H	1
Cheng, H; Du, YQ; Han, W; Hu, FL; Li, YQ; Li, ZS; Qian, KD; Shi, RH; Wu, QD; Zhang, GX	1
Anifanti, C; Doulgeroglou, V; Kamberoglou, D; Koutsoumbas, A; Krystallis, C; Pistiolas, D; Tzias, V	1
Chang, CY; Chen, CC; Chen, MJ; Cheng, TY; Lee, YC; Lin, JT; Liou, JM; Sheng, WH; Wang, HP; Wu, MS	1
D'Ercole, C; De Francesco, V; Hassan, C; Vaira, D; Zullo, A	1
Bağci, S; Erçin, CN; Kantarcioğlu, M; Kilciler, G; Polat, Z; Toros, AB; Uygun, A	1
Cristofari, F; De Francesco, V; Hassan, C; Manes, G; Scaccianoce, G; Zullo, A	1
Abdelfatah, M; Assem, M; El Azab, G; Rasheed, MA; Shastery, M	1
Huang, X; Li, Y; Shi, R; Yao, L; Zhang, G	1
Hsueh, PR; Lee, PI; Yang, JC	1
Gisbert, JP; Pajares, JM	1
Chang, JJ; Chang, LC; Chen, LW; Chien, RN; Fang, KM	1
Cuomo, A; Federico, A; Gravina, AG; Iovene, MR; Marmo, R; Miranda, A; Nardone, G; Rocco, A; Romano, M; Salerno, R; Sica, M; Tiso, A	1
Furuse, J; Itabashi, M; Iwamoto, N; Kitagawa, N; Konno, T; Miyazawa, T; Motoori, S; Saisho, H; Saito, S	1
Gu, WQ; Liang, X; Liu, WZ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q	1
Li, Y; Pan, X; Qian, B; Qiu, Y; Shi, R; Tang, Q; Yao, L; Zhang, G	1
Chang, CY; Chang, SC; Chen, MJ; Chian, H; Hung, HW; Lee, YC; Lin, JT; Liou, JM; Sheng, WH; Wang, YC; Wu, MS	1
Gisbert, JP; Molina-Infante, J	1
De Francesco, V; Vaira, D; Zullo, A	1
Lochmannová, J	1
Dazai, M; Kobayashi, Y; Kubo, K; Miyagishima, T; Oda, H; Ohnishi, S; Onishi, R; Ono, M; Suzuki, M; Tada, K; Takahashi, S; Takahashi, T; Yamamoto, J	1
Ghasemzadeh, A; Mobarez, AM; Taghvaei, T; Talebi Bezmin Abadi, A	1
Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS	1
Goh, KL; Navaratnam, P	1
Akkan Çetinkaya, Z; Düzgün, S; Erhan Altunöz, M; Günes, P; Güzelbulut, F; Ovünç Kurdas, O; Sezikli, M	1
Chang, CY; Chen, CC; Chen, MJ; Fang, YJ; Lee, JY; Lin, JT; Liou, JM; Sheng, WH; Wang, HP; Wu, MS	1
Choi, KH; Chung, WC; Jung, SH; Kang, BK; Kim, EJ; Lee, KM; Oak, JH; Paik, CN	1
Higuchi, W; Imamura, Y; Kanda, H; Nishiyama, A; Takano, T; Taneike, I; Yamamoto, T; Yoshida, K	1
Bauerfeind, P; Kaiser, P; Misselwitz, B; Vavricka, SR	1
Chen, XY; Ge, ZZ; Gu, LY; Li, XB; Lin, WW; Lu, H	1
Chiu, YC; Chuah, SK; Hsu, PI; Hu, ML; Hu, TH; Kuo, CM; Tai, WC; Wu, DC; Wu, KL	1
Berning, M; Krasz, S; Labenz, J; Miehlke, S; Morgner, A	1
Budak, A; Karczewska, E; Sito, E; Wojtas-Bonior, I; Zwolińska-Wcisło, M	1
Akyuz, F; Ermis, F; Kaymakoglu, S; Kurt, R; Mungan, Z; Nazik, H; Pinarbasi, B; Uyanikoglu, A	1
Basu, PP; Flynn, M; Krishnaswamy, N; Pacana, T; Rayapudi, K; Shah, NJ	1
Chuah, SK; Hsu, PI; Tsay, FW; Wu, DC	1
Emer, O; Kadayifci, A; Kantarcioglu, M; Ozcan, A; Polat, Z; Uygun, A	1
Cinar, K; Idılman, R; Ozden, A; Seven, G; Yakut, M	1
D'Arcy, S; Glocker, E; Lasseter, G; Lawson, AJ; McNulty, CA; Nichols, T; Shaw, I	1
Compare, D; Federico, A; Gravina, AG; Iovene, MR; Loguercio, C; Marmo, R; Miranda, A; Nardone, G; Pilloni, PA; Ricciardiello, L; Rocco, A; Romano, M	1
Chang, KC; Chiou, SS; Chiu, KW; Chiu, YC; Chou, YP; Chuah, SK; Hsu, PI; Hu, ML; Hu, TH; Tai, WC; Wu, DC; Wu, KL	1
Gisbert, JP	2
Graham, DY; Shiotani, A	1
Almela, P; Barrio, J; Bermejo, F; Bory, F; Calvet, X; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; Gisbert, JP; Guerra, I; Khorrami, S; Lamas, E; Modolell, I; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A	1
Akyuz, F; Ermis, F; Mungan, Z	1
Aresti-Zárate, S; Ayestarán, B; Campos, MR; Carrascosa, MF; Cobo, M; Cuadrado-Lavín, A; Dierssen-Sotos, T; Fernández-Pousa, A; González-Colominas, E; Hernández, M; Pascual, EL; Salcines-Caviedes, JR	1
Elisei, W; Picchio, M; Tursi, A	1
Chung, JW; Ha, M; Hahm, KB; Jeong, MH; Jeong, SH; Jo, Y; Jung, HY; Kim, YJ; Ko, KI; Kwon, KA; Lee, SJ; Na, BS; Na, S; Park, SK	1
Calvet, X; Graham, DY	1
Bizzarri, B; de'Angelis, GL; Manfredi, M	1
Azana, R; Boos, A; Conley, ME; Crawford, RI; Deans, GD; Hoang, L; Janz, L; Junker, A; Leo, SH; Morton, TL; Prendiville, J; Senger, C; Tilley, P; Turvey, SE	1
Buzás, GM	1
Chiu, KW; Chiu, YC; Chou, YP; Chuah, SK; Hsu, PI; Hu, ML; Hu, TH; Kuo, CM; Kuo, YH; Liang, CM; Tai, WC; Wu, DC; Wu, KL	1
Azzolini, F; Bedogni, G; Camellini, L; Cavina, M; Decembrino, F; Di Mario, F; Formisano, D; Iori, V; Sassatelli, R; Sereni, G; Tioli, C	1
Chen, YH; Chuah, SK; Hsieh, MC; Hsu, PI; Hu, HM; Kuo, CH; Kuo, FC; Liu, CJ; Tseng, HH; Wang, SS; Wu, DC	1
Bruzzese, V; De Francesco, V; Hassan, C; Repici, A; Ridola, L; Vaira, D; Zullo, A	1
Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Vilar, H	1
Jiang, Q; Pan, XL; Qian, J; Shang, L; Shi, RH; Tu, HM; Yang, YM; Ye, F; Zhang, GX; Zhang, J	1
Bloom, S; Daoud, Y; De Lorenzo, A; Di Caro, S; Di Renzo, L; Fini, L; Gasbarrini, A; Grizzi, F; McCartney, S	1
Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Hsu, SJ; Hsu, YC; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tseng, CH; Tseng, PH; Wang, HP; Wu, MS; Yang, UC	1
Breurec, S; Burucoa, C; Dia, D; Mbengue, M; Onambele, M; Raymond, J; Seck, A	1
Armuzzi, A; Bartolozzi, F; Cammarota, G; Candelli, M; Cremonini, F; Di Caro, S; Gasbarrini, A; Nista, EC; Santarelli, L; Zocco, MA	1
Chan, CK; Fung, FM; Gu, Q; Hu, WH; Lai, KC; Lam, SK; Wong, BC; Wong, WM; Xia, HH; Yee, YK; Yuen, MF	1
Angeletti, S; De Francesco, V; Hassan, C; Ierardi, E; Lorenzetti, R; Marignani, M; Morini, S; Zullo, A	1
Asaumi, N; Kiguchi, T; Masuda, K; Niiya, K; Niiya, M; Tanimoto, M; Yoshida, C	1
Cammarota, G; Candelli, M; Carloni, E; Cazzato, IA; Cremonini, F; Di Caro, S; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Santarelli, L; Zocco, MA	1
Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A	1
Asaumi, N; Niiya, K; Niiya, M; Shibakura, M; Tanimoto, M; Yoshida, C	1
Aoyama, N; Fukuda, M; Kachi, M; Kasuga, M; Kuroda, K; Maekawa, S; Miki, I; Shirasaka, D; Tamura, T; Wambura, C; Watanabe, Y	1
Qin, ZM; Yang, ZX; Zou, J	1
Branca, G; Cammarota, G; Cannizzaro, O; Cesaro, P; Cianci, R; di Caro, S; Fedeli, P; Gasbarrini, G; Lecca, PG; Martino, A	1
Blancas-Valencia, JM; Bosques-Padilla, FJ; Calderón-Lozano, IE; de Ariño Suárez, M; Garza-González, E; Orozco-Gámiz, A; Reed-SanRoman, G; Tamayo-de la Cuesta, JL; Valdovinos-Díaz, MA	1
Dohden, K; Hattori, M; Hayashi, H; Hosokawa, O; Kaizaki, Y	1
Branca, G; Cammarota, G; Fadda, G; Gasbarrini, A; Gasbarrini, GB; Schito, AM; Spanu, T	1
Candelli, M; Carloni, E; Cazzato, A; Di Campli, C; Fini, L; Gasbarrini, A; Gasbarrini, G; Nista, EC; Pignataro, G; Zocco, MA	1
Castro, LP; Cerqueira, MC; Cindr, JM; Coelho, LG; Gallo, MA; Mendonça, S; Moretzsohn, LD; Passos, MC; Pedrazzoli-Júnior, J; Ribeiro, ML; Vieira, WL; Vitiello, L	1
Arthurs, M; Barton, EN; Dowe, G; Lee, MG; Levy, V; Smikle, MF	1
Bernabucci, V; Cavina, M; De Francesco, V; Gatta, L; Hassan, C; Ierardi, E; Morini, S; Perna, F; Ricci, C; Tampieri, A; Vaira, D; Zullo, A	1
Consolazio, A; Crispino, P; Iacopini, F; Nardi, F; Palladini, D; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M	1
McLoughlin, RM; O'Connor, HJ; O'Morain, CA	1
Aoyama, N; Kasuga, M; Matsumoto, Y; Miki, I; Mitani, T; Miyachi, H; Morita, Y; Shirasaka, D; Tamura, T; Toyoda, M; Watanabe, Y	1
Jung, HC; Kim, JM; Kim, JS; Kim, N; Song, IS	1
Gisbert, JP; Morena, F	1
Bilardi, C; Dulbecco, P; Giannini, EG; Mamone, M; Mansi, C; Santi, ML; Savarino, V; Testa, R	2
Chan, AO; Chan, CK; Chu, KM; Fung, FM; Gu, Q; Lai, KC; Tong, TS; Wong, BC; Wong, WM; Yee, YK	1
Antos, D; Bästlein, E; Bayerdörffer, E; Buchner, M; Haferland, C; Hänel, C; Lehn, N; Meier, E; Schneider-Brachert, W; Stolte, M; Trump, F	1
Cho, YK; Jeon, WK; Kang, MS; Kim, BI; Kim, HJ; Oh, SY; Park, DI; Park, JH; Sohn, CI; Yoo, TW; Yun, JW	1
Benito, LM; Bermejo, F; Bory, F; Castro-Fernández, M; Cosme, A; Ducons, J; Fernández-Bermejo, M; Gisbert, JP; Lamas, E; López-Rivas, L; Olivares, D; Pabón, M; Pérez-Aisa, A	1
Bechor, J; Niv, Y; Samra, Z; Shmuely, H; Yahav, J	1
Chey, WD; Kim, HM; Saad, RJ; Schoenfeld, P	1
Vakil, N	1
Hunt, RH; Thabane, L; Yuan, Y	1
Cammarota, G; Cianci, R; Gasbarrini, GB; Montalto, M; Pandolfi, F	1
Cammarota, G; Candelli, M; Cazzato, A; Finizio, R; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Lauritano, EC; Nista, EC; Ojetti, V; Santoro, M; Zocco, MA	1
Hong, SP; Hwang, SG; Kim, S; Ko, KH; Kwon, CI; Lee, BS; Lee, JH; Park, PW; Phyun, LH; Rim, KS; Song, HU	1
Capodicasa, S; Cappello, G; Coraggio, D; Grossi, L; Marzio, L	1
Aoyama, N; Kasuga, M; Kinoshita, S; Kumagai, S; Matsumoto, Y; Miki, I; Mitani, T; Miyachi, H; Morita, Y; Okano, Y; Shirasaka, D; Tamura, T; Toyoda, M	1
Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P	1
Chang, CC; Chen, TH; Chiang, H; Chiu, HM; Lee, YC; Lin, JT; Liu, TY; Wang, HP; Wu, HM; Wu, MC; Wu, MS	1
Cammarota, G; Candelli, M; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Spada, C; Zocco, MA	1
Gisbert, JL; Gisbert, JP; Marcos, S; Moreno-Otero, R; Pajares, JM	2
Bensler, M; Bruce, MG; Carothers, JJ; Coleman, JM; Hennessy, TW; Hurlburt, DA; McMahon, BJ; Morris, JM; Parkinson, AJ; Reasonover, AL	1
Hassan, C; Morini, S; Perna, F; Ricci, C; Saracino, I; Vaira, D; Zullo, A	1
Fernández-Bermejo, M; Gisbert, JP; González-García, G; Mateos-Rodríguez, JM; Molina-Infante, J; Pérez-Gallardo, B; Prieto-Bermejo, AB; Robledo-Andrés, P	1
Cannaviello, C; De Francesco, V; Efrati, C; Hassan, C; Ierardi, E; Maconi, G; Manes, G; Morini, S; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A	1
Chang, WL; Chen, WY; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB	1
Bozzi, R; Cozzolino, A; Di Girolamo, E; Morante, A; Pasquale, L; Rispo, A	1
Almela, P; Barrio, J; Benito, LM; Bermejo, F; Bory, F; Calvet, X; Carneros, JA; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; García-Durán, F; Gisbert, JP; Khorrami, S; Lamas, E; Modolell, I; Niño, P; O'Callaghan, E; Ortiz, V; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A; Valer, MP	1
But, D; Chan, AO; Chan, CK; Chan, P; Cheung, TK; Chu, KM; Fung, J; Hsu, A; Hung, I; Wong, BC; Yee, YK; Yuen, MF	1
Hassan, C; Morini, S; Perna, F; Ricci, C; Vaira, D; Zullo, A	1
Katelaris, PH; Van der Poorten, D	1
Cantu, M; Ferguson, D; Page, RL	1
Gigliotti, F; Morini, S; Ricci, C; Vaira, D; Zullo, A	1
Chan, FK; Lee, CC; Lee, VW; Ling, TK	1
Chen, A; Hsu, PI; Lai, KH; Lo, GH; Lu, CY; Peng, NJ; Tsay, FW; Tseng, HH; Wu, DC; Yu, FJ	1
Hirayama, F; Ikeda, Y; Kawakita, T; Kuroda, T; Moriguchi, A; Sakurai, N; Sano, M; Uemori, S; Yamamoto, K	1
Arancio, F; Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Cuoco, L; Gasbarrini, A; Gasbarrini, G; Pirozzi, G; Santarelli, L; Zocco, MA	1
Hassan, C; Lorenzetti, R; Morini, S; Zullo, A	1

Reviews

22 review(s) available for ofloxacin and Infections, Helicobacter

Article	Year
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication). Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:7 Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Treatment Failure	2013
Second and third line treatment options for Helicobacter pylori eradication. World journal of gastroenterology, 2014, Feb-14, Volume: 20, Issue:6 Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Moxifloxacin; Ofloxacin; Rifabutin; Rifamycins; Rifaximin; Salvage Therapy; Virulence Factors	2014
[The new aspects of the eradication of Helicobacter pylori and the importance of bacterial resistance]. Orvosi hetilap, 2008, Oct-26, Volume: 149, Issue:43 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Patient Compliance; Proton Pump Inhibitors; Risk Factors; Salvage Therapy; Treatment Failure	2008
[Effectiveness and safety of proton pump inhibitor and levofloxacin based first-line triple therapy in the eradication of Helicobacter pylori: a meta-analysis]. Zhonghua yi xue za zhi, 2008, Oct-21, Volume: 88, Issue:38 Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Proton Pump Inhibitors	2008
Helicobacter pylori: diagnosis and treatment. Current opinion in gastroenterology, 2009, Volume: 25, Issue:6 Topics: Amoxicillin; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Treatment Failure	2009
Helicobacter pylori eradication therapy. Future microbiology, 2010, Volume: 5, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome	2010
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis. Wiener klinische Wochenschrift, 2010, Volume: 122, Issue:13-14 Topics: Anti-Infective Agents; Aza Compounds; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Proton Pump Inhibitors; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Retreatment	2010
Treatment of Helicobacter pylori infection: the past and the future. European journal of internal medicine, 2010, Volume: 21, Issue:5 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ofloxacin	2010
[Current perspective of the resistance of Helicobacter pylori strains to antimicrobial drugs]. Klinicka mikrobiologie a infekcni lekarstvi, 2010, Volume: 16, Issue:6 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors	2010
[New options for helicobacter pylori antibiotic treatment]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:28-29 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Precision Medicine; Proton Pump Inhibitors; Retreatment; Stomach Diseases; Treatment Failure	2011
[Current value of quinolones in Helicobacter pylori therapy]. Zeitschrift fur Gastroenterologie, 2011, Volume: 49, Issue:8 Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	2011
A new look at anti-Helicobacter pylori therapy. World journal of gastroenterology, 2011, Sep-21, Volume: 17, Issue:35 Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Tetracycline	2011
Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia. Journal of clinical immunology, 2012, Volume: 32, Issue:6 Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Chronic Disease; Ertapenem; Genetic Diseases, X-Linked; Helicobacter; Helicobacter Infections; Humans; Male; Ofloxacin; Phylogeny; Treatment Outcome	2012
[Helicobacter pylori - 2012]. Orvosi hetilap, 2012, Sep-09, Volume: 153, Issue:36 Topics: Algorithms; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Emigrants and Immigrants; Endoscopy, Gastrointestinal; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; In Situ Hybridization, Fluorescence; Levofloxacin; Ofloxacin; Peptic Ulcer; Polymerase Chain Reaction; Stomach Neoplasms	2012
Modified sequential therapy regimens for Helicobacter pylori eradication: a systematic review. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Volume: 45, Issue:1 Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Tetracycline; Treatment Outcome	2013
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line. World journal of gastroenterology, 2012, Oct-28, Volume: 18, Issue:40 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chi-Square Distribution; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Odds Ratio; Ofloxacin; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome	2012
Treatment of H. pylori infection: a review. Current medicinal chemistry, 2005, Volume: 12, Issue:4 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Clarithromycin; Fluoroquinolones; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Ofloxacin; Polypharmacy; Ranitidine; Rifabutin	2005
Eradication of Helicobacter pylori: recent advances in treatment. Fundamental & clinical pharmacology, 2005, Volume: 19, Issue:4 Topics: Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Patient Compliance; Rifabutin; Time Factors; Treatment Failure	2005
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Alimentary pharmacology & therapeutics, 2006, Jan-01, Volume: 23, Issue:1 Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Treatment Failure	2006
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. The American journal of gastroenterology, 2006, Volume: 101, Issue:3 Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline	2006
Third-line rescue therapy for Helicobacter pylori infection. World journal of gastroenterology, 2006, Apr-21, Volume: 12, Issue:15 Topics: Anti-Bacterial Agents; Doxycycline; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Ofloxacin; Rifabutin; Rifampin; Treatment Failure	2006
[Treatment for Helicobacter pylori: current criteria]. Recenti progressi in medicina, 2007, Volume: 98, Issue:11 Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Tinidazole; Treatment Outcome	2007

Trials

63 trial(s) available for ofloxacin and Infections, Helicobacter

Article	Year
Antofloxacin-based bismuth quadruple therapy is safe and effective in Helicobacter pylori eradication: A prospective, open-label, randomized trial. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2021, Volume: 22, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ofloxacin; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome	2021
Efficacy and Safety of Antofloxacin-Based Triple Therapy for Helicobacter pylori Eradication Failure in China. Digestive diseases and sciences, 2022, Volume: 67, Issue:1 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; China; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Proton Pump Inhibitors; Treatment Outcome	2022
Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy. Helicobacter, 2013, Volume: 18, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pilot Projects; Prospective Studies; Treatment Outcome; Urea; Young Adult	2013
Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study. Helicobacter, 2013, Volume: 18, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Pilot Projects; Treatment Outcome; Turkey; Young Adult	2013
[Efficacy of levofloxacin-based triple therapy as second-line Helicobacter pylori eradication]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 51, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organometallic Compounds; Pantoprazole; Time Factors; Treatment Outcome	2008
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Salvage Therapy; Young Adult	2009
Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options. Helicobacter, 2008, Volume: 13, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Doxycycline; Female; Furazolidone; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Rabeprazole; Treatment Failure; Treatment Outcome; Urea	2008
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:5 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Salvage Therapy; Tetracycline; Treatment Outcome; Young Adult	2009
Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication. BMC gastroenterology, 2009, May-26, Volume: 9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Salvage Therapy; Treatment Outcome	2009
Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong? Helicobacter, 2009, Volume: 14, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin	2009
The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey. Helicobacter, 2009, Volume: 14, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Rabeprazole; Treatment Outcome; Turkey; Young Adult	2009
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome	2010
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult	2010
[Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study]. Zhonghua yi xue za zhi, 2010, Jan-12, Volume: 90, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Young Adult	2010
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. Gut, 2010, Volume: 59, Issue:5 Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Treatment Outcome; Young Adult	2010
Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2010, Volume: 21, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Middle Aged; Ofloxacin	2010
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study. European journal of internal medicine, 2010, Volume: 21, Issue:4 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Single-Blind Method; Young Adult	2010
Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study. International journal of clinical practice, 2010, Volume: 64, Issue:11 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2010
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut, 2010, Volume: 59, Issue:11 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Costs; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome; Young Adult	2010
Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Ch Clinical therapeutics, 2010, Volume: 32, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Rabeprazole	2010
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Breath Tests; Cytochrome P-450 CYP2C19; DNA Gyrase; Drug Monitoring; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome; Urea	2011
Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial. Journal of Korean medical science, 2011, Volume: 26, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Peptic Ulcer; Prospective Studies; Rifamycins; Rifaximin	2011
Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study. Helicobacter, 2011, Volume: 16, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; China; Drug Therapy, Combination; Female; Fluoroquinolones; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organometallic Compounds; Pantoprazole; Pilot Projects; Salvage Therapy; Treatment Outcome; Young Adult	2011
Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori. The American journal of the medical sciences, 2011, Volume: 342, Issue:3 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome	2011
Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer. Southern medical journal, 2011, Volume: 104, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Peptic Ulcer; Treatment Outcome; Young Adult	2011
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. The American journal of gastroenterology, 2011, Volume: 106, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Levofloxacin; Male; Middle Aged; Nitro Compounds; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Recurrence; Thiazoles; Young Adult	2011
Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. European journal of internal medicine, 2012, Volume: 23, Issue:2 Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Retrospective Studies; Treatment Outcome; Young Adult	2012
Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2011, Volume: 22, Issue:6 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors	2011
Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. Gastroenterology, 2012, Volume: 143, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Tinidazole; Treatment Outcome; Young Adult	2012
Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori. Helicobacter, 2012, Volume: 17, Issue:3 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Taiwan	2012
Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:9 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Single-Blind Method; Spain; Time Factors; Treatment Outcome; Urea; Young Adult	2012
Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. Journal of gastrointestinal and liver diseases : JGLD, 2012, Volume: 21, Issue:2 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome	2012
Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate. Helicobacter, 2012, Volume: 17, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult	2012
The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study. Helicobacter, 2012, Volume: 17, Issue:5 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Proton Pump Inhibitors; Taiwan; Time Factors; Treatment Outcome; Urea	2012
Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Organometallic Compounds; Surveys and Questionnaires; Treatment Outcome; Young Adult	2013
Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China. Helicobacter, 2012, Volume: 17, Issue:6 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Breath Tests; China; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Outcome; Urea; Young Adult	2012
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet (London, England), 2013, Jan-19, Volume: 381, Issue:9862 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Ofloxacin	2013
Levofloxacin based regimens for the eradication of Helicobacter pylori. European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Patient Compliance; Prospective Studies; Treatment Outcome	2002
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2003, Feb-15, Volume: 17, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Rabeprazole; Rifabutin; Treatment Outcome	2003
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Alimentary pharmacology & therapeutics, 2003, Sep-15, Volume: 18, Issue:6 Topics: Adolescent; Adult; Aged; Antacids; Anti-Infective Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Patient Compliance; Prospective Studies; Treatment Outcome	2003
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'. Alimentary pharmacology & therapeutics, 2003, Oct-15, Volume: 18, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea	2003
[Laboratory and clinical study of levofloxacin against Helicobacter pylori]. Zhonghua yi xue za zhi, 2003, Oct-25, Volume: 83, Issue:20 Topics: Adolescent; Adult; Aged; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin	2003
High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication. Journal of clinical gastroenterology, 2004, Volume: 38, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Rabeprazole; Treatment Outcome	2004
Open, randomized multicenter comparative trial of rabeprazole, ofloxacin and amoxicillin therapy for Helicobacter pylori eradication: 7 vs. 14 day treatment. Helicobacter, 2004, Volume: 9, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mexico; Middle Aged; Ofloxacin; Omeprazole; Rabeprazole; Time Factors; Treatment Outcome	2004
One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:8 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Patient Compliance; Treatment Outcome	2005
Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:11 Topics: Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies	2005
A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2006, Jan-15, Volume: 23, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Pilot Projects; Rabeprazole; Time Factors; Tinidazole; Treatment Outcome	2006
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2006, Feb-01, Volume: 23, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome	2006
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity. Helicobacter, 2006, Volume: 11, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2006
[Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2006, Volume: 47, Issue:1 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin	2006
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. The American journal of gastroenterology, 2006, Volume: 101, Issue:2 Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure	2006
Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study. Digestive diseases (Basel, Switzerland), 2006, Volume: 24, Issue:1-2 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Rifamycins; Rifaximin; Treatment Outcome	2006
Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole. Journal of clinical gastroenterology, 2006, Volume: 40, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Breath Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Omeprazole; Pilot Projects; Rabeprazole; Tinidazole; Treatment Outcome	2006
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. The American journal of gastroenterology, 2006, Volume: 101, Issue:9 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2006
Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Alimentary pharmacology & therapeutics, 2006, Nov-15, Volume: 24, Issue:10 Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Rifabutin; Treatment Failure	2006
Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure. Helicobacter, 2007, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Ranitidine; Treatment Failure; Treatment Outcome	2007
First-line triple therapy with levofloxacin for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2007, Aug-01, Volume: 26, Issue:3 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Ranitidine; Treatment Outcome	2007
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Levofloxacin; Male; Middle Aged; Ofloxacin; Rabeprazole; Tinidazole; Treatment Outcome	2007
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy. Helicobacter, 2007, Volume: 12, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Constipation; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Nausea; Ofloxacin; Treatment Outcome; Vomiting	2007
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. The American journal of gastroenterology, 2008, Volume: 103, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Urea	2008
Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2007, Oct-01, Volume: 26, Issue:7 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Outcome	2007
Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Retreatment	2007
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studies; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Tinidazole	2000

Other Studies

64 other study(ies) available for ofloxacin and Infections, Helicobacter

Article	Year
Education and imaging. Gastrointestinal: colonic mucosa-associated lymphoid tissue lymphoma regressed by levofloxacin. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colonic Neoplasms; Colonoscopy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Endosonography; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Multimodal Imaging; Occult Blood; Ofloxacin; Polymerase Chain Reaction; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Novel agent for Helicobacter pylori infection management. Chinese medical journal, 2013, Volume: 126, Issue:23 Topics: Animals; Anti-Bacterial Agents; Escherichia coli; Female; Galactosylceramides; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Intestines; Levofloxacin; Lymphocyte Activation; Male; Natural Killer T-Cells; Ofloxacin; Sphingomonas; Stomach	2013
Letter: levofloxacin resistance - a challenge for the treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin	2017
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. Journal of clinical pathology, 2008, Volume: 61, Issue:10 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Chi-Square Distribution; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tetracycline Resistance; Treatment Failure	2008
Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication. The Netherlands journal of medicine, 2009, Volume: 67, Issue:3 Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors	2009
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure; Young Adult	2009
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Treatment Outcome	2010
Helicobacter pylori: antibiotic resistance and treatment options. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:7 Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure	2009
How to manage Helicobacter pylori after sequential therapy failure? Journal of clinical gastroenterology, 2010, Volume: 44, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Child; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Ofloxacin; Rabeprazole; Treatment Failure; Treatment Outcome	2010
Antibiotic resistance of Helicobacter pylori in Israeli children. Scandinavian journal of gastroenterology, 2010, Volume: 45, Issue:5 Topics: Adolescent; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Biopsy; Chi-Square Distribution; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Prospective Studies; Surveys and Questionnaires; Tetracycline; Treatment Failure	2010
A new second-line sequential regimen for Helicobacter pylori eradication based on levofloxacin: a pilot study. Digestive diseases and sciences, 2010, Volume: 55, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Young Adult	2010
Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:11 Topics: Adolescent; Adult; Aged; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tinidazole; Young Adult	2010
Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice. Journal of gastrointestinal and liver diseases : JGLD, 2010, Volume: 19, Issue:2 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Time Factors; Treatment Failure	2010
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11 Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline	2010
[A case of mucosa-associated lymphoid tissue lymphoma with penicillin allergy successfully treated with levofloxacin, minomycin and rabeprazole]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biopsy; Drug Hypersensitivity; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Minocycline; Ofloxacin; Penicillins; Rabeprazole	2010
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World journal of gastroenterology, 2010, Oct-28, Volume: 16, Issue:40 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Retrospective Studies; Young Adult	2010
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3 Topics: Adult; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Randomized Controlled Trials as Topic; RNA, Ribosomal, 23S; Treatment Outcome	2011
Levofloxacin in first-line eradication regimens for Helicobacter pylori: better test antibiotic susceptibility before treating. Gut, 2011, Volume: 60, Issue:11 Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Ofloxacin	2011
Sequential therapy for Helicobacter pylori eradication: is levofloxacin better? Gut, 2011, Volume: 60, Issue:11 Topics: Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Ofloxacin	2011
[Repetition of Helicobacter cinaedi infections during chemotherapy for malignant lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:12 Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefozopran; Cephalosporins; Cyclophosphamide; Doxorubicin; Helicobacter; Helicobacter Infections; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Ofloxacin; Prednisolone; Remission Induction; Stomach Neoplasms; Vincristine	2010
Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Internal and emergency medicine, 2012, Volume: 7, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Young Adult	2012
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 57, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline	2011
High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia. Helicobacter, 2011, Volume: 16, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies	2011
Application of levofloxacine in the second phase of sequential therapy regimen for Helicobacter pylori eradication: is it a good choice? Minerva medica, 2011, Volume: 102, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Ofloxacin; Prospective Studies; Treatment Outcome	2011
Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Bacterial Agents; Drug Combinations; Fluoroquinolones; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin	2011
Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland. Pharmacological reports : PR, 2011, Volume: 63, Issue:3 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Poland	2011
Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:10 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Endoscopy; England; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Risk Factors; Wales	2012
Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:12 Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Proton Pump Inhibitors; Time Factors; Treatment Outcome	2012
Which Therapy for Helicobacter pylori Infection? Gastroenterology, 2012, Volume: 143, Issue:1 Topics: Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Ofloxacin	2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients. Journal of clinical gastroenterology, 2013, Volume: 47, Issue:2 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Spain; Surveys and Questionnaires; Time Factors; Treatment Failure	2013
Recurrence of Helicobacter pylori After Eradication in Patients with Peptic Ulcer. Southern medical journal, 2012, Volume: 105, Issue:6 Topics: Amoxicillin; Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Ofloxacin; Omeprazole	2012
[Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Jun-25, Volume: 59, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Rifabutin; Salvage Therapy	2012
Guide regarding choice of second-line therapy to obtain a high cumulative cure rate. Helicobacter, 2012, Volume: 17, Issue:4 Topics: Anti-Bacterial Agents; Female; Helicobacter Infections; Humans; Male; Ofloxacin	2012
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. World journal of gastroenterology, 2012, Sep-07, Volume: 18, Issue:33 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Clarithromycin; Comorbidity; Disease Eradication; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome; Ulcer; Young Adult	2012
Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery. Obesity surgery, 2013, Volume: 23, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Ofloxacin; Portugal; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Surgical Wound Infection; Treatment Failure; Young Adult	2013
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients. Annals of clinical microbiology and antimicrobials, 2013, Jan-08, Volume: 12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; RNA, Ribosomal, 23S; Senegal; Tetracycline; Young Adult	2013
A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Glossitis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome; Urea	2003
[Helicobacter pylori eradication based upon a drug sensitivity test effectively increased platelet count in a patient with refractory idiopathic thrombocytopenic purpura]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Ofloxacin; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic	2003
Secondary eradication of Helicobacter pylori was effective against refractory idiopathic thrombocytopenic purpura. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Blood Platelets; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Minocycline; Ofloxacin; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic	2003
Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure	2003
Regression of rectal mucosa-associated lymphoid tissue lymphoma but persistence of Helicobacter pylori infection of gastric mucosa after administration of levofloxacin: report of a case. Diseases of the colon and rectum, 2004, Volume: 47, Issue:9 Topics: Anti-Infective Agents; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Levofloxacin; Lymphoma; Middle Aged; Ofloxacin; Rectal Neoplasms; Treatment Outcome	2004
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. International journal of antimicrobial agents, 2004, Volume: 24, Issue:5 Topics: Clarithromycin; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Nitroimidazoles; Ofloxacin; Proton Pump Inhibitors; Treatment Failure	2004
New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study. Alimentary pharmacology & therapeutics, 2005, Mar-15, Volume: 21, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Benzimidazoles; Drug Combinations; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Pilot Projects; Rabeprazole; Treatment Outcome	2005
Antibiotic sensitivity of Helicobacter pylori in Jamaica. The West Indian medical journal, 2004, Volume: 53, Issue:6 Topics: Aged; Breath Tests; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Jamaica; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Trimethoprim, Sulfamethoxazole Drug Combination	2004
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses. Alimentary pharmacology & therapeutics, 2005, Jul-01, Volume: 22, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Drug Evaluation; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2005
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Point Mutation; Quinolines; Sequence Analysis, DNA	2005
Rescue therapy with levofloxacin after multiple H. pylori treatment failures. Alimentary pharmacology & therapeutics, 2005, Oct-01, Volume: 22, Issue:7 Topics: Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Treatment Failure	2005
In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure. Diagnostic microbiology and infectious disease, 2006, Volume: 55, Issue:1 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Treatment Failure	2006
Helicobacter pylori treatment: a practical approach. The American journal of gastroenterology, 2006, Volume: 101, Issue:3 Topics: Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Treatment Outcome	2006
Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence? Alimentary pharmacology & therapeutics, 2006, Apr-15, Volume: 23, Issue:8 Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Treatment Failure	2006
[The efficacy of levofloxacin based triple therapy for Helicobacter pylori eradication]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2006, Volume: 48, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin	2006
Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole. Helicobacter, 2006, Volume: 11, Issue:4 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Breath Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Endoscopy, Digestive System; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Treatment Outcome; Urease	2006
Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan. Helicobacter, 2006, Volume: 11, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; Sequence Analysis, DNA	2006
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment. The American journal of gastroenterology, 2006, Volume: 101, Issue:8 Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure	2006
A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures. Helicobacter, 2006, Volume: 11, Issue:5 Topics: Anti-Bacterial Agents; Delivery of Health Care; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Failure; Treatment Outcome	2006
The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jan-15, Volume: 44, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin	2007
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Alimentary pharmacology & therapeutics, 2007, Jun-15, Volume: 25, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome	2007
Levofloxacin in first-line treatment of Helicobacter pylori infection. Helicobacter, 2007, Volume: 12, Issue:4 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Ofloxacin; Treatment Outcome	2007
The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice. Alimentary pharmacology & therapeutics, 2007, Volume: 26, Issue:11-12 Topics: Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ofloxacin; Prospective Studies; Proton Pump Inhibitors; Rifabutin	2007
An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure. Cardiology, 2008, Volume: 110, Issue:2 Topics: Amoxicillin; Anti-Bacterial Agents; Comorbidity; Drug Therapy, Combination; Heart Failure; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Proton Pump Inhibitors	2008
Levofloxacin-resistant Helicobacter pylori in Hong Kong. Chemotherapy, 2008, Volume: 54, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Ketolides; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Point Mutation; Tetracycline	2008
Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures. European journal of clinical investigation, 2008, Volume: 38, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Chi-Square Distribution; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organometallic Compounds; Patient Selection; Polymorphism, Genetic; Prospective Studies; Rabeprazole; Salvage Therapy; Treatment Outcome	2008
Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents. Bioorganic & medicinal chemistry letters, 1998, Aug-18, Volume: 8, Issue:16 Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Stability; Fluoroquinolones; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indicators and Reagents; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Ofloxacin; Quinolones; Solutions; Structure-Activity Relationship; Ultraviolet Rays	1998
Helicobacter pylori eradication: do we have another ace up our sleeve? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001, Volume: 33, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Anti-Infective Agents; Benzimidazoles; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Ofloxacin; Omeprazole; Rabeprazole	2001